secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dyne Therapeutics, Inc. (DYN)
CIK:        0001818794
Form:       8-K
Filed at:   2026-06-22T20:15:29+00:00
Accession:  0001818794-26-000005
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Barry E. Greene elected to Dyne Therapeutics board; receives option for 57,463 shares
--------------------------------------------------------------------------------

- Elected as Class I director effective June 22, 2026, to serve until 2027 annual meeting.
- Received option for 57,463 shares at $20.87 per share, vesting monthly over 3 years.
- Will receive $45,000 annual cash retainer and standard equity grants per non-employee director program.
- No committee appointments; board determined independent per Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818794/000181879426000005/0001818794-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818794/000181879426000005/dyn-20260622.htm
  HTML page:      https://secwatch.observer/filing/0001818794-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer